SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-044557
Filing Date
2023-04-12
Accepted
2023-04-12 16:02:01
Documents
6
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm231885-1_def14a.htm DEF 14A 707248
2 GRAPHIC bc_companytsr-4c.jpg GRAPHIC 115974
3 GRAPHIC bc_netloss-4c.jpg GRAPHIC 106547
4 GRAPHIC lg_protagonist-pn.jpg GRAPHIC 48835
5 GRAPHIC px_01page-bw.jpg GRAPHIC 678459
6 GRAPHIC px_02page-bw.jpg GRAPHIC 643578
  Complete submission text file 0001104659-23-044557.txt   2651803
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37852 | Film No.: 23815661
SIC: 2834 Pharmaceutical Preparations